Chemours Stock Rises After $455 Million PFAS Settlement in North Carolina
The Chemours Company (NYSE:CC) shares rose on Thursday following a $455 million settlement with North Carolina and local entities over PFAS-related claims. The agreement, reached alongside DuPont de Nemours (DD) and Corteva (CTVA), resolves litigation tied to contamination from Fayetteville Works and other sites. Chemours' portion of the payment is covered by existing accruals, reducing financial uncertainty. The settlement eliminates future escrow contributions required under a 2021 Memorandum of Understanding and addresses remaining obligations related to drinking water programs in North Carolina. The company stated that this agreement provides clarity on legacy liabilities and supports ongoing operations at Fayetteville Works. Despite the broader market weakness—S&P 500 down 0.43% and Materials sector falling 1.24%—Chemours shares gained 1.53%, trading at $15.27. Technically, Chemours remains in a recovery phase but is still below key moving averages. Momentum indicators suggest easing selling pressure as buyers gain traction.
Topics: corporate settlement PFAS litigation stock price movement